NCT00590785 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00590785/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Cyclophosphamide [clinicaltrials_resource:214e8af3b1ddfa5080aebe39469226b1]G-CSF [clinicaltrials_resource:74110e27f503c1868a21a09ae40e4eed]Doxorubicin [clinicaltrials_resource:bf052018f5c56c235c80fad39abf6e5c]tamoxifen [clinicaltrials_resource:fa284953afab1a17f7230868b13070c6]clinicaltrials:NCT00590785
arm group [clinicaltrials_vocabulary:arm-group]
NCT00590785 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00590785/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Bio2RDF identifier
NCT00590785/arm-group/c4ca4238a0b923820dcc509a6f75849b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ca4238a0b923820dcc509a6f75849b
identifier
clinicaltrials_resource:NCT00590785/arm-group/c4ca4238a0b923820dcc509a6f75849b
title
NCT00590785 arm group c4ca4238a0b923820dcc509a6f75849b
@en
type
label
NCT00590785 arm group c4ca4238 ...... a4238a0b923820dcc509a6f75849b]
@en